Pharmacological differences among angiotensin II receptor antagonists

Blood Pressure, Supplement

Volumn 10, Issue 2, 2001, Pages 13-18

  Belz, G G ^a  

^a Ctr for Cardiovascular Pharmacology   (Germany)

Author keywords

Aldosterone; Angiotensin II receptor antagonists; Candesartan; Irbesartan; Radioligand receptor assay; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN; EPROSARTAN; IRBESARTAN; LOSARTAN; RENIN; TELMISARTAN; VALSARTAN; ALDOSTERONE; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT;

BIOAVAILABILITY; CONFERENCE PAPER; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG TOLERABILITY; HUMAN; HYPERTENSION; PHARMACODYNAMICS; PRIORITY JOURNAL; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; REVIEW;

ALDOSTERONE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; RECEPTORS, ANGIOTENSIN; RENIN;

EID: 0034952704     PISSN: 08038023     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370501750275848     Document Type: Conference Paper

References (31)

1. Irbesartan: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension
2. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: Efficacy and safety compared with placebo and enalapril
3. Efficacy and tolerability of losartan potassium and atenololin patients with mild to moderate essential hypertension
4. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: A comparative study of the efficacy and safety against amlodipine
5. Angiotensin II receptor blockade and end-organ protection
6. Comparative antihypertensive efficacy of angiotensin receptor blockers (ARBs)
7. 1 receptor antagonists: The role of tight antagonist binding
8. Newly emerging pharmacologic differences in angiotensin II receptor blockers
9. Comparative pharmacodynamics and pharmacokinetics of candesartan and losartan in man
10. Tasosartan, enoltasosartan, and angiotensin II receptor blockade: The confounding role of protein binding
11. Full antagonism of pressor response to exogenous angiotensin II (AII) by single-dose irbesartan in normotensive subjects
12. Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects
13. Time course and extent of angiotensin II antagonism following irbesartan, losartan and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay
14. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT-1 receptor antagonists
15. 1-receptor antagonists: Correlation with complementary LC data reveals a potential contribution of active metabolites
16. Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man
17. Assessment of angiotensin II receptor blockade in humans using a standardized angiotensin II receptor-binding assay
18. The renin-angiotensin system and its receptors
19. Aldosterone antagonism in heart failure
20. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators
21. Extent and duration of angiotensin II antagonistic activity of irbesartan and candesartan cilexetil
22. 1-receptor mediated effects than does candesartan cilexetil as evidenced by higher plasma renin levels
23. 1-receptor medicated effects than does candesartan cilexetil as evidenced by blunted plasma aldosterone levels
24. 1-receptor blockers in isolated vessels of different origin